X4 Pharmaceuticals Inc.

NASDAQ: XFOR · Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.80
-1.41%
After-hours: Aug 15, 2025, 07:54 PM EDT

X4 Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.94 -1.47 -0.65 -0.57
PEG Ratio
0.06 0.02 0.01 -0.02
PS Ratio
57.69 n/a n/a n/a
PB Ratio
6.66 2.92 0.83 0.79
P/FCF Ratio
-1.12 -1.54 -0.8 -0.71
P/OCF Ratio
-1.13 -1.55 -0.8 -0.72
OCF/S Ratio
-51.19 n/a n/a n/a
Debt / Equity Ratio
3.53 1.14 0.52 0.62
Quick Ratio
3.33 5.34 5.76 6.27
Current Ratio
3.41 5.34 5.76 6.27
Asset Turnover
0.02 n/a n/a n/a
Interest Coverage
-4.15 -18.61 -21.93 -23.37
Return on Equity
-1.69 -1.98 -1.27 -1.38
Return on Assets
-0.26 -0.69 -0.6 -0.76
Return on Invested Capital
-0.32 -0.85 -0.65 -0.81
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.69 n/a n/a n/a
Net Profit Margin
-14.65 n/a n/a n/a
Pretax Profit Margin
-14.52 n/a n/a n/a
Operating Profit Margin
-14.24 n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-10.78 n/a n/a n/a